Latest Safety News

Minbos Resources edges closer to operational readiness at Cabinda with a US$1.3 million initial drawdown from Banco de Fomento Angola and steel framework shipment underway for Phase 2 construction.

Evolution Energy Minerals has confirmed its Chilalo coarse flake graphite is well-suited for high-value fuel cell applications, including separator plates critical to data centre power and fuel-cell electric vehicles.

Nexalis Therapeutics reports a 52% rise in half-year losses to $1.3 million amid funding facility cancellation and clinical trial suspensions, highlighting ongoing cash flow challenges.

Actinogen Medical has locked in full underwriting for nearly 127 million unlisted options, guaranteeing $4.77 million in fresh funding as it approaches pivotal Alzheimer’s trial results due in November.

Simble Solutions has demonstrated its NanoSensor platform detecting volatile organic compounds at molecular sensitivity, marking a key step towards commercial gas sensing applications integrated with its digital platforms.

Percheron Therapeutics has raised $2.3 million through an institutional placement to fully fund its upcoming acute myeloid leukemia clinical trial led by Vanderbilt Health.

Racura Oncology has launched patient enrolment at its first Korean site for the CPACS Phase 1 trial, aiming to accelerate recruitment and validate RC220’s safety and efficacy in a key oncology market.

Ramsay Health Care has finalised its $251 million purchase of National Capital Private Hospital in Canberra, expanding its footprint in key therapeutic areas and expecting earnings accretion within a year.

Collins Foods posted record FY26 revenue and underlying profit, exited Taco Bell to focus on KFC growth, and outlined ambitious expansion plans in Germany and Australia.

Babylon Pump & Power reported a $5.2 million EBITDA loss in FY26 amid legacy maintenance struggles but saw its rental segment revenue surge 160%. The company exited maintenance post-year end and raised $7.27 million to strengthen its balance sheet and fund rental growth.

Cycliq Group Limited reported a 20.7% revenue decline to AUD 3.79 million for FY2026, but reduced its net loss by 83% to AUD 85,897, driven by disciplined cost control and strategic platform investments.

ClearVue Technologies saw a 35% revenue decline to $161,000 and a $11 million net loss in FY2026, driven by a major operational overhaul and significant product certification efforts. Despite the financial setback, the company expanded into new markets and secured key commercial projects.